U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599982) titled 'Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes' on May 14.
Brief Summary: A 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI) in conjunction with continuous glucose monitoring (CGM).
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes (T1D)
Intervention:
DEVICE: MODI Algorithm
All participants use MODI insulin titration algorithm. Includes Diary app used to view trea...